SURMOUNT-1 Trial: The Landmark Study The SURMOUNT-1 trial, published in The New England Journal of Medicine , studied 2,539 adults with obesity (BMI 30+) or overweight (BMI 27+) with at least one weight-related comorbidity
PlexusDx sources compounded semaglutide from licensed 503A compounding pharmacies that follow strict FDA standards and quality controls
Once reconstituted with a sterile laboratory solvent, store at 28C and avoid repeated freeze/thaw cycles to maintain compound integrity
Frequently Asked Questions Is $129 per month actually affordable for ongoing GLP-1 treatment
Symptoms include: Swelling of the face, lips, tongue, or throat Difficulty breathing or swallowing Severe rash or hives Rapid heartbeat These require immediate emergency medical care
doi: 10.1038/clpt.2008.35